-15.3%
WDAY vs MRNA
+511.3%
-526.6%
-54.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.4% | -2.2% | -3.1% | -5.3% |
| 7D | -4.4% | +5.5% | -9.8% | -4.5% |
| 30D | +14.7% | +158.7% | -144.0% | +11.0% |
| 3M | +32.4% | +182.1% | -149.8% | +29.4% |
| 6M | +36.9% | +151.8% | -114.9% | +34.7% |
| YTD | -8.8% | +393.6% | -402.4% | -12.7% |
| 1Y | -15.3% | +499.5% | -514.8% | -20.5% |
| All | -15.3% | +511.3% | -526.6% | -20.5% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling